Philips acquired BioTelemetry, a leading provider of remote cardiac diagnostics and monitoring, in early 2021. BioTelemetry’s portfolio delivers the widest range of remote cardiac monitors with a unique cardiac data platform, AI-based data analytics for chronic disease management and clinical trial services.
- BioTel Heart brings one of the world’s largest remote cardiac monitoring services networks to Philips cardiac care portfolio, enabling connected end-to-end cardiac care pathways from hospital to home and home to hospital.
- BioTel Care enhances Philips remote patient monitoring for chronic disease management.
- BioTel Research provides a comprehensive suite of services and technologies to support traditional, hybrid and decentralized clinical trials.